Abstract

Liquidia Technologies Inc will post second-quarter results on August 12, 2026 Pre-MKt, with investors watching revenue acceleration, profitability mix, and updated guidance for the second half of 2026.

Market Forecast

For the current quarter, market projections indicate total revenue of 168.54 million US dollars, up 40.67% year over year, EBIT of 74.29 million US dollars with an implied 303.08% year-over-year increase, and EPS of 0.74 with an implied 272.32% year-over-year increase. Based on the latest model, gross margin is expected to remain high given the company’s mix, and net margin should track operating leverage; adjusted EPS is projected to expand alongside revenue growth. The company’s main business is product sales, supported by a small service component; the outlook emphasizes execution in core commercial channels and disciplined cost control. The most promising near-term segment is product sales, expected to account for the majority of revenue; strong growth combined with high contribution margin underpins the year-over-year expansion.

Last Quarter Review

In the previous quarter, Liquidia Technologies Inc reported revenue of 132.87 million US dollars, a gross profit margin of 91.08%, GAAP net profit attributable to the parent company of 52.86 million US dollars with a net profit margin of 39.79%, and adjusted EPS of 0.52, with revenue rising 41.58% year over year and adjusted EPS up 215.56% year over year. Operating performance outpaced forecasts as EBIT reached 61.50 million US dollars, exceeding estimates by 13.86 million US dollars; execution on operating expenses and unit economics supported the upside. Main business highlights: product sales delivered 129.88 million US dollars while services contributed 2.98 million US dollars; product sales remained the primary growth engine.

Current Quarter Outlook

Main commercial portfolio

Management focus centers on sustaining high gross margin while scaling distribution and patient access, with revenue guided to 168.54 million US dollars and a year-over-year increase of 40.67%. The combination of high contribution margin and operating discipline should support operating leverage, pointing to potential expansion in adjusted EPS, currently forecast at 0.74. Watch for commentary on channel inventory, pricing, and payer dynamics, which could influence realized margins and cash conversion within the quarter.

Product sales as the key growth vector

Product sales remain the dominant revenue stream and the largest driver of quarterly variance. With last quarter’s product revenue at 129.88 million US dollars and a gross margin base above 90%, incremental volume tends to flow through at attractive margins. The quarter’s growth algorithm will likely hinge on unit uptake trends, new account additions, and any co-promotion or field-force productivity updates that may accelerate net sales.

Stock price swing factors this quarter

Share performance will be sensitive to any changes in revenue trajectory versus the 168.54 million US dollars consensus, including signals on order momentum and demand sustainability. Profitability mix is another swing factor: sustaining a gross margin profile near last quarter’s 91.08% and executing on operating cost plans would support the forecasted EBIT of 74.29 million US dollars and EPS of 0.74. Any updates to the second-half cadence, including timing of potential milestones or label and market access developments, could shift expectations, particularly if they alter the pace of operating leverage or revenue mix.

Analyst Opinions

Bullish opinions dominate recent commentary. Analysts highlighting the setup point to accelerating top-line growth of 40.67% year over year for the quarter, a step-up in operating leverage implied by the 74.29 million US dollars EBIT estimate, and a healthy adjusted EPS projection of 0.74. The consensus view argues that last quarter’s outperformance versus estimates and the high-90s gross margin foundation reduce downside risk to profitability. The bullish camp expects execution on the core product franchise to extend revenue momentum, while ongoing cost discipline should keep net margin tracking favorably relative to sales growth.